0001645113-21-000105.txt : 20210903 0001645113-21-000105.hdr.sgml : 20210903 20210903163436 ACCESSION NUMBER: 0001645113-21-000105 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20210901 FILED AS OF DATE: 20210903 DATE AS OF CHANGE: 20210903 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Burke William Patrick CENTRAL INDEX KEY: 0001880493 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37565 FILM NUMBER: 211237000 MAIL ADDRESS: STREET 1: 195 COMMERCE WAY CITY: PORTSMOUTH STATE: NH ZIP: 03801 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NovoCure Ltd CENTRAL INDEX KEY: 0001645113 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: NO. 4 THE FORUM STREET 2: GRENVILLE STREET CITY: ST. HELIER STATE: Y9 ZIP: JE2 4UF BUSINESS PHONE: 44 (0)15 3475 6700 MAIL ADDRESS: STREET 1: NO. 4 THE FORUM STREET 2: GRENVILLE STREET CITY: ST. HELIER STATE: Y9 ZIP: JE2 4UF FORMER COMPANY: FORMER CONFORMED NAME: Novocure Ltd DATE OF NAME CHANGE: 20150615 3 1 wf-form3_163070126218711.xml FORM 3 X0206 3 2021-09-01 0 0001645113 NovoCure Ltd NVCR 0001880493 Burke William Patrick 20 VALLEY STREAM PARKWAY SUITE 300 MALVERN PA 19355 0 1 0 0 Chief Human Resources Officer Ordinary Shares 10283 D Restricted Share Units 2657 D Restricted Share Units 4804 D Restricted Share Units 1573 D Restricted Share Units 3266 D Restricted Share Units 3634 D Options to Buy Ordinary Shares 11.46 2026-02-24 Ordinary Shares 17452.0 D Options to Buy Ordinary Shares 7.15 2027-02-21 Ordinary Shares 9750.0 D Options to Buy Ordinary Shares 21.6 2027-10-30 Ordinary Shares 7500.0 D Options to Buy Ordinary Shares 21.15 2028-02-26 Ordinary Shares 32103.0 D Options to Buy Ordinary Shares 47.04 2029-03-21 Ordinary Shares 10946.0 D Options to Buy Ordinary Shares 69.37 2030-03-02 Ordinary Shares 13896.0 D Options to Buy Ordinary Shares 84.68 2030-08-31 Ordinary Shares 4535.0 D Options to Buy Ordinary Shares 153.09 2031-03-01 Ordinary Shares 6001.0 D Options to Buy Ordinary Shares 137.58 2031-08-31 Ordinary Shares 6531.0 D Represents restricted share units that are scheduled to vest on March 22, 2022, subject to the reporting person's continued employment through such date. Represents restricted share units that are scheduled to vest on March 3, 2022 and 2023, subject to the reporting person's continued employment through such dates. Represents restricted share units that are scheduled to vest on September 1, 2022 and 2023, subject to the reporting person's continued employment through such dates. Represents restricted share units that are scheduled to vest on March 2, 2022, 2023 and 2024, subject to the reporting person's continued employment through such dates. Represents restricted share units that are scheduled to vest on September 1, 2022, 2023 and 2024, subject to the reporting person's continued employment through such dates. Fully vested as of the date hereof. These options vest on October 31, 2021, subject to the reporting person's continued employment through such date. Options to buy 32,103 ordinary shares, 24,078 shares of which are currently exercisable and the remaining 8,025 vest and become exercisable on February 27, 2022, subject to the reporting person's continued employment through such date. Options to buy 10,946 ordinary shares, 3,649 shares of which are currently exercisable and the remaining 7,297 shares of which will vest and become exercisable in equal installments on each of March 22, 2022 March 22, 2023, subject to the reporting person's continued employment through such dates. Options to buy 13,896 ordinary shares, 3,474 shares of which are currently exercisable and the remaining 10,422 shares will vest and become exercisable in equal installments on each of March 3, 2022, March 3, 2023 and March 3, 2024, subject to the reporting person's continued employment through such dates. Options to buy 4,535 ordinary shares, 1,134 shares of which are currently exercisable and the remaining 3,401 shares will vest and become exercisable in equal installments on each of September 1, 2022, September 1, 2023 and September 1, 2024, subject to the reporting person's continued employment through such dates. One-quarter of these options is scheduled to vest on each of March 2, 2022, March 2, 2023, March 2, 2024 and March 2, 2025, subject to the reporting person's continued employment through such dates. One-quarter of these options is scheduled to vest on each of September 1, 2022, September 1, 2023, September 1, 2024 and September 1, 2025, subject to the reporting person's continued employment through such dates. By: /s/ Steven Robbins, Attorney in Fact for William Patrick Burke 2021-09-03 EX-24 2 ex-24.htm POWER OF ATTORNEY - WPBURKE - 2021-09-01
Power of Attorney - Burke - 2021-09-01
LIMITED POWER OF ATTORNEY FOR
SECTION 16 REPORTING PURPOSES

Know all by these presents, that the undersigned hereby makes, constitutes and appoints Todd Longsworth, Kimberly Burke, Carrie Kane and Steven Robbins, acting individually, as the undersigned's true and lawful attorneys-in-fact, with full power and authority as hereinafter described on behalf of and in the name, place and stead of the undersigned to:

(1) execute for, and on behalf of, the undersigned, in the undersigned's capacity as an officer, director and/or 10% beneficial owner of Novocure Limited (the "Company"), Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules and regulations promulgated thereunder (the "Exchange Act");

(2) seek or obtain, as the undersigned's representative and on the undersigned's behalf, information on transactions in the Company's securities from any third party, including brokers, employee benefit plan administrators and trustees, and the undersigned hereby authorizes any such person to release any such information to any attorneys-in-fact and further approves and ratifies any such release of information;

(3) do and perform any and all acts for and on behalf of the undersigned that may be necessary or desirable to prepare, complete and execute any such Form 3, 4 or 5, and any amendments thereto, or other required report and timely file such Forms or reports with the United States Securities and Exchange Commission, the New York Stock Exchange and any stock exchange or similar authority as considered necessary or advisable under Section 16(a) of the Exchange Act; and

(4) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorneys-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorneys-in-fact on behalf of the undersigned pursuant to this Limited Power of Attorney shall be in such form and shall contain such terms and conditions as such attorneys-in-fact may approve in such attorney-in-fact's sole discretion.

The undersigned hereby gives and grants to each such attorneys-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorneys-in-fact, or such attorneys-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted.

The undersigned hereby acknowledges that (a) the foregoing attorneys-in-fact are serving in such capacity at the request of the undersigned; (b) this Limited Power of Attorney authorizes, but does not require, each such attorneys-in-fact to act in his or her discretion on information provided to such attorneys-in-fact without independent verification of such information; (c) any documents prepared and/or executed by any attorneys-in-fact on behalf of the undersigned pursuant to this Limited Power of Attorney shall be in such form and shall contain such information and disclosure as such attorneys-in-fact, in his or her sole discretion, deems necessary or advisable; (d) neither the Company nor any attorneys-in-fact assumes (i) any liability for the undersigned's responsibility to comply with the requirements of the Exchange Act,
(ii) any liability of the undersigned for any failure to comply with such requirements or (iii) any obligation or liability of the undersigned for profit disgorgement under Section 16(b) of the Exchange Act; and (e) this Limited Power of Attorney does not relieve the undersigned from responsibility for compliance with the undersigned's obligations under the Exchange Act, including, without limitation, the reporting requirements under Section 16 of the Exchange Act.

This Limited Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned's holdings of, and transactions in, securities issued by the Company, unless earlier revoked as to any attorneys-in-fact by the undersigned in a signed writing delivered to such attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 1 day of September, 2021.

/s/ William P. Burke
Signature

William P. Burke
Print Name